Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Pharmaceutical Group is a prominent state-owned pharmaceutical enterprise based in Beijing and a core subsidiary of China Resources Pharmaceutical Group (CR Pharma). The company operates across the entire pharmaceutical value chain, including research and development, large-scale manufacturing, and extensive logistics and distribution. Its portfolio is managed through several high-profile subsidiaries such as China Resources Double-Crane and China Resources Zizhu, which lead the market in cardiovascular, endocrine, and reproductive health therapies. As a key player in the Chinese healthcare sector, the group provides a wide range of essential chemical drugs, biologics, and traditional Chinese medicines. The company also maintains one of the most significant pharmaceutical supply chain networks in Northern China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京医药集团.